Photo: NDTV
Covaxin Safe For Children Aged 2-18, Finishes Clinical Trials: BBIL
Bharat Biotech International Limited (BBIL) announced that after phase II/III trials, Covaxin can safely be administered to children between ages two and 18. Reportedly, the phases II/III studies were conducted to evaluate the safety, reactogenicity and immunogenicity of the vaccine in healthy children and adolescents. "We have now achieved our goal of developing safe and efficacious Covid-19 vaccine for adults and children," said Dr Krishna… read-more
Tags: Covaxin, BBIL, Covid-19, Covid Vaccine, children vaccine
Courtesy: ANI
Photo: U.S. News
FDA To Evaluate Moderna Vaccine For Children Aged 12-17 By Jan 2022
Moderna Inc stated that US Food and Drug Administration (FDA) requested more time to finish its evaluation of the company's Covid-19 vaccine for teenagers aged 12-17 years on October 31. FDA evaluation may not be finished until January 2022, which might delay the issuance of an emergency use authorization (EUA)… read-more
Tags: Moderna, Covid-19, Covid Vaccine, FDA, children vaccine
Courtesy: Reuters
